Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1733 clinical trials
Selinexor With Combination With Induction/Consolidation Therapy in Acute Myeloid Leukemia Patients

. Selinexor may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as cytarabine and daunorubicin hydrochloride, work in different ways to

  • 13 views
  • 05 Jun, 2022
  • 1 location
Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer

gene put in them that makes them able to recognize TAG72, a protein on the surface of tumor cells. These TAG72-specific T cells may help the body's immune system identify and kill TAG72+ cancer cells

  • 0 views
  • 04 Oct, 2022
  • 1 location
Phase 2 Clinical Trial for Comprehensive Treatment Program for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Tagraxofusp (SL-401) in Combination With HCVAD/Mini-CVD and VENETOCLAX

cells by blocking some of the enzymes needed for cell growth. SL-401 is a recombinant protein consisting of IL-3 linked to a toxic agent called DT. IL-3 attaches to IL-3 receptors on tumor cells in a

  • 0 views
  • 15 Oct, 2022
  • 1 location
Nivolumab and ADI-PEG 20 Before Surgery for the Treatment of Resectable Liver Cancer

monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. ADI-PEG 20 may stop the growth of tumor

  • 0 views
  • 04 Oct, 2022
  • 1 location
Daratumumab-Based Maintenance in Patients With Relapsed Multiple Myeloma After Salvage Autologous Stem Cell Transplantation

. Daratumumab and hyaluronidase-fihj is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Chemotherapy drugs, such as pomalidomide, work in different ways to stop the

growth factor
platelet count
daratumumab
withdrawn
tumor cells
  • 2 views
  • 23 Oct, 2022
  • 1 location
Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma

chemotherapy, such as doxorubicin hydrochloride, vinblastine, and dacarbazine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by

doxorubicin
vinblastine
adriamycin
lymphoma
neutrophil count
  • 0 views
  • 07 Oct, 2022
  • 1 location
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer

To evaluate the feasibility of administering HCQ, EVE or the combination in patients who have completed primary therapy for breast cancer and harbor bone marrow disseminated tumor cells.

invasive breast cancer
tumor cells
triple-negative breast cancer
primary tumor
cancer
  • 24 views
  • 14 Jun, 2022
  • 1 location
  • 0 views
  • 29 Jun, 2022
  • 3 locations
Pembrolizumab and a Vaccine (ATL-DC) for the Treatment of Surgically Accessible Recurrent Glioblastoma

ability of tumor cells to grow and spread. Vaccines, such as ATL-DC vaccine, may help the body build an effective immune response to kill tumor cells. Giving pembrolizumab and ATL-DC vaccine may work

glioblastoma multiforme
nitrosoureas
karnofsky performance status
neutrophil count
vaccine therapy
  • 9 views
  • 19 Apr, 2022
  • 1 location
PSMA PET and MRI in Gynecological Cancers

cancer cells in the body.

Accepts healthy volunteers
cancer
  • 0 views
  • 29 May, 2022
  • 1 location